| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
| 12,600 | 33,473 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
| 12,600 | 33,473 | | | Operating Expenses | | Research Development | 109,670 | 70,364 | 56,968 | | Selling General and Administrative | 27,044 | 21,763 | 19,552 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (136,714) | (79,527) | (43,047) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,439 | 5,476 | 5,700 | | Earnings Before Interest And Taxes | (132,275) | (74,051) | (37,347) | | Interest Expense | 160 | 221 | 290 | | Income Before Tax | (132,435) | (74,272) | (37,637) | | Income Tax Expense | (89) |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (132,346) | (74,272) | (37,637) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (132,346) | (74,272) | (37,637) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($132,346) | ($74,272) | ($37,637) |
|
0.34% Nasdaq 0.00%
Income Statement
